SEPN Septerna Corp: Earnings per share for the last twelve months

Official company branding of Septerna Inc (SEPN)

Geopolitical fragmentation is hindering the global exchange of technology, yet Septerna Inc (SEPN) remains focused on the internal development of its GPCR platform and venture capital. The 12-month net income per share snapshot resolves this contradiction, with the latest value recorded as -1.28. The asset's stability is constrained by strict FDA oversight and the company's robust patent protection of its intellectual property.

Septerna Inc (SEPN) - Net earnings per share (EPS TTM) from 10/26/2024 to 11/12/2026

Analytical breakdowns and data insights for company Septerna, Inc. (SEPN)

- current quotes and average value forecast:
Price Chart Septerna Inc|SEPN - Consensus Target
- company stock capitalization data:
Market Value Septerna Inc|SEPN - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value per Share Septerna|SEPN - Book Capitalization|Market Value to Book Value Ratio septerna.com|SEPN - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Septerna Inc|SEPN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Septerna Corp|SEPN - Company Total Debt Obligations|Debts to Book Capitalization Septerna Inc|SEPN - Long-Term Debt|Company Short-Term Debt Septerna|Quick Liquidity Indicator septerna.com
- earnings and valuation multiples indicators:
SEPN - Profit After Payment of Taxes|Projected Future Earnings Septerna Inc|SEPN - Market Cap to Earnings|Future Price to Earnings Septerna|SEPN - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Septerna Inc|SEPN - Operating profit before amortization|Net earnings per share (EPS TTM) Septerna|SEPN - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months septerna.com|SEPN - Earnings per share increase in current year|Earnings growth forecast for next year Septerna Inc
Fundamental company analysis:Septerna Inc (SEPN)
Manufactured products of Septerna Corp

For Septerna Inc (SEPN), the annual earnings per share trend reflects the capitalization efficiency of the Native GPCR platform and the pace of advancing oral drugs into the clinic. This indicator is calculated as the ratio of net income over a rolling year to the number of shares, allowing the market to filter out noise and objectively compare the biotech's profitability against industry benchmarks to assess asset quality.

Main competitors

ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|AUPH - Earnings per share for the last twelve months|Net earnings per share for the last four quarters BioCryst Corp BCRX|VERA: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months dianthustx.com (DNTH)|Earnings per share for the last twelve months Pharvaris|AbCellera Biologics Inc - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months TRML (Tourmaline Corp)|Earnings per share for the last four quarters PGEN|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|nektar.com (NKTR) - Net earnings per one share for the last twelve months|UPB - Earnings per share for the last twelve months|Earnings per share for the trailing year ZBIO (Zenas Bio)|Immunome Corp (IMNM) - Earnings per share for the last twelve months|Earnings per share for the last 12 months GOSS|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) pieris.com|Net earnings per share for the last 12 months SVRA (Savara)|RIGL (Rigel Pharma) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ANAB (AnaptysBio Corp)|Net earnings per share for the last four quarters Astria Corp (ATXS)|ENGN - Earnings per share for the last twelve months|RAPT (RAPT Therapeutics Inc.) - Earnings per share for the last 12 months|JBIO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Aclaris Therapeutics Inc.|Earnings per share for the last twelve months Kyverna|Tiziana Life Sciences, Ltd. (TLSA) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) CABA|VTYX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Theratechnologies THTX|AVTX (Avalo Therapeutics, Inc.) - Earnings per one share for the last 12 months|ELDN - Earnings per share for the last twelve months|AGEN (Agenus, Inc) - Earnings per share for the last 12 months|Climb Bio Inc (CLYM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZURA (Zura Bio Ltd)|ATYR (aTyr Pharma) - Net earnings per share (EPS TTM)|ADAG: Earnings per share for the trailing year|Net earnings per share (EPS TTM) IMA|Net earnings per share (EPS TTM) shattucklabs.com (STTK)|Earnings per share for the last twelve months Equillium EQ|Earnings per share for the trailing year CNTB|IMUX - Earnings per share for the last twelve months|Atara Biotherapeutics (ATRA) - Net earnings per share for the last 12 months|IFRX: Net earnings per share (EPS TTM)|X4 Pharmaceuticals, Inc (XFOR) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ACET|CELU: Earnings per share for the trailing year|Net earnings per share (EPS TTM) INMB|Net earnings per share for the last four quarters Barinthus Biotherapeutics PLC|Earnings per share for the last twelve months Kezar Life Sciences, Inc KZR|SABS - Net earnings per share for the last 12 months|AKTX - Earnings per share for the last twelve months|Enlivex Therapeutics (ENLV) - Net earnings per share for the last 12 months|QTTB (q32bio.com) - Net earnings per share for the last 12 months|GeoVax Labs (GOVX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Edesa|Earnings per share for the last 12 months IBIO (iBio Corporation)|Net earnings per share (EPS TTM) CARM|XTLB - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Bolt Biotherapeutics, Inc. BOLT|Net earnings per share for the last four quarters HCW Biologics, Inc. (HCWB)|Aptevo - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AIM ImmunoTech, Inc.|aditxt.com (ADTX) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months GRI (gribio.com)|Net earnings per share for the last 12 months XRTX|HIND (Vyome Holdings Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) REVB|INDP - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Scinai Immunotherapeutics SCNI|Earnings per share for the trailing year CALI|AFMD - Earnings per share for the last twelve months|ALLK (Allakos Inc.) - Earnings per share for the last 12 months|HOOK: Net earnings per share (EPS TTM)|IGM Biosciences (IGMS) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ITOS|OCEA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TCBP|Net earnings per share for the last four quarters Third Harmonic Bio Inc.